Table 3.
Associated comorbidities in Italian fibromyalgia patients treated with medical cannabis
| Comorbidities | N = 38 | |
|---|---|---|
| Patients | % | |
| Hypovitaminosis D with or without osteoporosis/osteopenia | 17 | 44.7 |
| Hypertension | 15 | 39.5 |
| Depression | 12 | 31.6 |
| Osteoarthritis | 11 | 28.9 |
| Hiatal hernia | 8 | 21.1 |
| Hypothyroidism | 6 | 15.8 |
| Hypercholesterolemia | 6 | 15.8 |
| Tachycardia/atrial fibrillation | 4 | 10.5 |
| Irritable colon | 4 | 10.5 |
| Diabetes | 4 | 10.5 |
| Hyperuricemia | 4 | 10.5 |
| Psoriasis | 3 | 7.9 |
| Carpal tunnel syndrome | 3 | 7.9 |
| Raynaud syndrome | 3 | 7.9 |
| Pulmonary thromboembolism | 2 | 5.3 |
| Liver disease | 2 | 5.3 |
| Glaucoma | 2 | 5.3 |
| Endometriosis | 2 | 5.3 |
| Kidney failure | 1 | 2.6 |
| Ischemic heart disease | 1 | 2.6 |
| Skin fungus | 1 | 2.6 |
| Vasculopathy | 1 | 2.6 |
| Anemia | 1 | 2.6 |
| OSAS | 1 | 2.6 |
| Duodenal ulcer | 1 | 2.6 |
| Sjogren syndrome | 1 | 2.6 |
N number of patients, OSAS obstructive sleep apnea syndrome. Comorbidities of 38 patients with fibromyalgia syndrome treated with medical cannabis at an Italian pain clinic